2020-06-12T23:57:01Zhttps:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi
oai:pubmedcentral.nih.gov:23738682008-12-29procbpmc-open
Proc Biol Sci RSPB Proceedings of the Royal Society B: Biological Sciences 0962-8452 1471-2954 The Royal Society London PMC2373868 PMC2373868 2373868 18292054 rspb20071713 10.1098/rspb.2007.1713 18292054 Research Article CD4+T cells do not mediate within-host competition between genetically diverse malaria parasites Barclay Victoria C 1 * Råberg Lars 2 Chan Brian H.K 1 † Brown Sheila 1 Gray David 1 Read Andrew F 1 † School of Biological Sciences, University of Edinburgh Edinburgh EH9 3JT, UK Department of Animal Ecology, Lund University 223 62 Lund, Sweden Author and address for correspondence: Centre for Infectious Disease Dynamics, Departments of Biology and Entomology, Pennsylvania State University, 208 Mueller Building, University Park, PA 16802, USA (victoria.barclay@ed.ac.uk)

Centre for Infectious Disease Dynamics, Departments of Biology and Entomology, Pennsylvania State University, 208 Mueller Building, University Park, PA 16802, USA.

20 2 2008 22 5 2008 275 1639 1171 1179 14 12 2007 31 1 2008 Copyright © 2008 The Royal Society 2008

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Ecological interactions between microparasite populations in the same host are an important source of selection on pathogen traits such as virulence and drug resistance. In the rodent malaria model Plasmodium chabaudi in laboratory mice, parasites that are more virulent can competitively suppress less virulent parasites in mixed infections. There is evidence that some of this suppression is due to immune-mediated apparent competition, where an immune response elicited by one parasite population suppress the population density of another. This raises the question whether enhanced immunity following vaccination would intensify competitive interactions, thus strengthening selection for virulence in Plasmodium populations. Using the P. chabaudi model, we studied mixed infections of virulent and avirulent genotypes in CD4+T cell-depleted mice. Enhanced efficacy of CD4+T cell-dependent responses is the aim of several candidate malaria vaccines. We hypothesized that if immune-mediated interactions were involved in competition, removal of the CD4+T cells would alleviate competitive suppression of the avirulent parasite. Instead, we found no alleviation of competition in the acute phase, and significant enhancement of competitive suppression after parasite densities had peaked. Thus, the host immune response may actually be alleviating other forms of competition, such as that over red blood cells. Our results suggest that the CD4+-dependent immune response, and mechanisms that act to enhance it such as vaccination, may not have the undesirable affect of exacerbating within-host competition and hence the strength of this source of selection for virulence.

malaria CD4+T cells competition
1. Introduction

Parasitic infections are often genetically diverse, with hosts concurrently infected by more than one genotype. Crowding, where pathogen populations within a host are suppressed by the presence of competitor strains, could affect the health and infectiousness of individual hosts as well as the evolution of medically relevant traits such as virulence and drug resistance (Read & Taylor 2001). For example, selection for increased virulence is expected when a slower growing parasite is outcompeted by a faster growing, more virulent parasite (Bremermann & Pickering 1983; van Baalan & Sabelis 1995; Frank 1996; Gandon et al. 2001; Alder & Losada 2002). Similarly, the relative fitness of drug-resistant strains, and hence their rate of spread in a population, could be substantially enhanced when co-infecting drug-sensitive competitors are removed by chemotherapy (e.g. Hastings 1997, 2003, 2006; Mackinnon & Hastings 1998; Hastings & D'Alessandro 2000; Mackinnon 2005). Analogous evolutionary processes could affect the rate of evolution of epitope variants in response to strain-specific vaccination (Lipsitch & Samore 2002; Read & Mackinnon 2008).

Infections with the human malaria parasite Plasmodium falciparum frequently consist of more than one genotype (Anderson et al. 2000; Awadalla et al. 2001; Jafari et al. 2004; Walliker et al. 2005), and a variety of epidemiological evidence is consistent with crowding (Daubersies et al. 1996; Mercereau-Puijalon 1996; Arnot 1998; Smith et al. 1999; Bruce et al. 2000; Hastings 2003; Talisuna et al. 2006). In the rodent malaria model Plasmodium chabaudi in laboratory mice, there is a strong relationship between parasite virulence and crowding such that more virulent strains have a competitive advantage (de Roode et al. 2003, 2005a,b; Bell et al. 2006).

A number of biological mechanisms may underlie competition between strains within hosts (Read & Taylor 2001). One of these is immune-mediated apparent competition (Holt 1977), where increasing densities of one pathogen population elicits a host response that suppresses the population of another. T cell-dependent immune-mediated competition has been demonstrated in P. chabaudi (Råberg et al. 2006): in nude mice, which cannot produce mature T cells, competition was less severe than in nude mice reconstituted with T cells. Because many malaria vaccines currently under trial are aimed at inducing T cell-dependent responses, that experiment raised the question of whether vaccination might exacerbate in-host competition and thus affect pathogen evolution, for instance by strengthening selection for competitive ability and hence virulence.

The effects of immunity on in-host competition are unlikely to be simple. The immune response to Plasmodium infection has both pathogen genotype-transcending (non-specific) and genotype-specific components. Protection is generally thought to become more specific during later stages of infection (Jarra & Brown 1989; Buckling & Read 2001; Mackinnon & Read 2003; Stevenson & Riley 2004; Martinelli et al. 2005; Cheesman et al. 2006). Thus, in contrast to non-specific immunity that could generate immune-mediated apparent competition, specific immunity could, in principle, act to alleviate competition (Råberg et al. 2006). Here, we extend the study by Råberg et al. (2006) by focusing on a specific subset of T cells, in order to further investigate the importance of immunity in determining competitive outcomes within hosts.

T cells can be divided into two major categories, CD4+ and CD8+ cells. It is well established from both experimental animal models and field studies in humans that the CD4+T cells play a pivotal role in the development of blood stage immunity to Plasmodium infection (Good & Doolan 1999; Pombo et al. 2002). They are initially required to produce cytokines that amplify the phagocytic and parasitocidal response of the innate immune response and later on to dampen this response to limit immunopathology. As the response becomes more adaptive they are required to help B cells produce antibodies that are essential for parasite clearance (Urban et al. 2005; Stephens & Langhorne 2006).

Since the CD4+T cells have been described as having such a crucial role in natural immunity to the blood stage of infection, and vaccine programmes strive to mimic and enhance this response (e.g. Stephens & Langhorne 2006), we have begun to investigate the specific role of these cells during competition in mixed infections of P. chabaudi. Specifically we looked at the acute phase of infection, where any interaction between the parasite and the host immune response could strongly influence host health (Urban et al. 2005). We chose two parasite genotypes that had been shown previously to differ in competitive ability and compared the extent of competition in immuno-competent and CD4+T cell-depleted mice. We hypothesized two possible scenarios: (i) if T cell-dependent immunity induces a non-specific response, then a numerically subdominant clone would experience a stronger immune response in a mixed infection than when on its own. Thus, competition should be eased in CD4+T cell-depleted mice. (ii) If the immune response is largely clone-specific and primarily elicited against the numerically dominant clone, then CD4+T cell depletion may exacerbate other forms of competition, such as competition for limited resources such as red blood cells.

2. Material and methods (a) Parasites and hosts

Isolates of P. chabaudi were originally collected from Thamnomys rutilans in the Central African Republic (Beale et al. 1978). These isolates have been genotyped and are stored as frozen stabilates in liquid nitrogen with subscript codes used to identify their position in the clonal history (Mackinnon & Read 1999). Two genotypes, AS12062 and DK108, were chosen based on their relative virulence and non-lethality. Pilot studies showed that clone DK achieved higher parasite densities when clone AS was absent than when AS was present. In contrast, clone AS was not competitively suppressed by DK. Hosts were inbred female C57BL/6JolaHsd mice aged six to eight weeks (Harlan England) maintained as described previously (de Roode et al. 2004).

(b) Depletion of CD4<sup>+</sup>T lymphocytes <italic>in vivo</italic>

A rat monoclonal antibody, GK1.5, was used to deplete the CD4+T cells. A non-depleting rat monoclonal antibody of the same isotype (IgG 14131, Sigma) was used as a control. Experimental mice were injected intraperitoneally with 500 μg of the appropriate purified antibody in phosphate-buffered saline (PBS) 5 days before parasite challenge, and then with 250 μg antibody 4 days and 1 day before parasite challenge and weekly after challenge.

A fluorescence-activated cell sorter (FACS) was used to confirm CD4+T cell depletion. From the tail snip, 20 μl of blood was taken 1 day prior to injection with the appropriate antibodies. Single cell suspensions were made by removing red blood cells using Lympholyte according to the manufacturer's instructions (Cedarlane, Canada). Approximately 1×106 cells were then transferred to a round-bottomed plate and resuspended in FACS buffer (PBS with 2% FCS with 0.05% sodium azide) before incubation for 20 min at 4°C with Allophycocyanin (APC)-labelled anti-CD4+ antibody (Pharmingen). The cells were washed three times in FACS buffer. Samples were collected on a FACS Calibre and 10 000 live events were collected for the majority of samples. FlowJo (TreeStar, CA) was used to analyse the data.

(c) Experimental setup and sampling

Groups of five mice were treated with: (i) control antibodies and challenged with 106 AS parasites, (ii) control antibodies and challenged with 106 DK parasites, (iii) control antibodies and challenged with 106 AS and 106 DK, (iv) anti-CD4 antibodies and challenged with 106 AS, (v) anti-CD4 antibodies and challenged with 106 DK, and (vi) anti-CD4 antibodies and challenged with 106 AS and 106 DK.

Parasites were delivered by intraperitoneal injection. We used the same dose of each genotype in single and mixed infections (rather than the same total dose in single and mixed infections) because the aim of the study was to compare the performance of a genotype when it is on its own, with its performance when it is in a mixed infection. A twofold difference in infective dose has negligible effects on the population dynamics of the parasite (Timms et al. 2001). In addition, we included two extra control groups, each of two mice that were not challenged with malaria, one group treated with anti-CD4 antibodies and another group with control antibodies. These mice were used to check whether CD4+T cell depletion was continuous throughout the experiment, as the number of peripheral T cells was lower than normal during the acute stage of disease (Hviid et al. 1997).

During the course of infection, we measured body weights and took blood samples from the tail to make Giemsa-stained blood smears and to estimate RBC density (by flow cytometry; Beckman Coulter) and for genotype-specific real-time quantitative PCR (qPCR) assays.

One mouse died during the experiment (CD4+T cell-depleted, mixed infection) and was included in the analyses only where possible. For unknown reasons, two infections (both non-depleted, a DK-only and an AS-only) achieved a peak parasite density two orders of magnitude lower than all others, and these were excluded from all the analyses.

(d) Quantitative PCR

Samples were taken in the morning as this is the stage when most parasites are in the ring or early trophozoite stage in the peripheral blood, when parasite ploidy is stable (de Roode et al. 2004). From each mouse, 5 μl of tail blood was taken and added to 100 μl of citrate saline on ice. Samples were subsequently pelleted by centrifugation and the citrate saline was removed. Blood was stored at −80°C until required. DNA extraction was performed using the BloodPrep kit (Applied Biosystems) on the ABI PRISM 6100 Nucleic Acid prep-station according to the manufacturer's instructions. DNA was eluted in a total volume of 200 μl and stored at −80°C until quantification. Genotype-specific qPCR was performed as described previously (Bell et al. 2006) with the addition of the DK-specific reverse primer: 5′-AGG CAT GTT TTG CAC ACA ATG A-3′.

(e) Trait definition and statistical analyses

We define competitive suppression to be a reduction of parasite numbers when another clone is present, which we tested for by comparing the performance of a clone in single and mixed infections. Performance was measured as the clonal density summed over a defined time period. Plasmodium chabaudi has a 24 hour replication cycle, so the total number of parasites present in any period can be estimated by summing the daily parasite counts. Thus, to test whether competitive suppression was CD4+T cell mediated, we asked, for each clone, whether the magnitude of any competitive suppression differed between intact control and CD4+T cell-depleted hosts; that is, whether there was a statistical interaction between immune treatment (intact control versus CD4+T cell-depleted hosts) and infection type (single versus mixed).

The effects of competition and CD4+ depletion on the performance of individual clone and red blood cell density were first examined by using general linear models (GLM) in the statistical package Minitab (release 14, Minitab, Inc.,). For GLM analysis, response variables included mean total parasite density and mean RBC density, with initial RBC as a covariate. Explanatory variables for GLM included CD4+ depletion (depleted or intact control) and competition (clone alone or in mixed infection). Maximal models (response variable = CD4+ depletion + competition + all higher order interactions) were tested in the first instance, and minimal models were obtained by dropping non-significant terms successively, beginning with highest order interactions, to obtain the significant minimal model. Second, we used repeated-measures analyses that take into account the importance of day post-infection. These analyses were performed as described by Råberg et al. (2006) using the statistical package SAS v. 9.1 (SAS Institute 1999, SAS OnlineDoc. v. 8. SAS Institute, Cary, NC). Briefly, the analyses were performed with PROC MIXED, using the REPEATED statement (subject=mouse), the Satterthwaite approximation of the denominator degrees of freedom, and the autoregressive covariance structure AR(1). Within each treatment group, the peak day varied ±2 days, presumably as a result of slight differences in inoculation dose. To control for this variation, we centred the peak day at the median peak day within each treatment group. All density data were transformed using [log(density +10)].

3. Results

Mice treated with the anti-CD4+T cell antibody were successfully depleted of CD4+T cells, both prior to parasite challenge and during the whole course of the experiment (figure 1). The CD4+T cell depletion resulted in more parasites of both clones (figure 2a,b; table 1).

(a) Clone DK

As found with other pairs of clones (de Roode et al. 2005a,b; Bell et al. 2006), here we found that the relatively avirulent clone was competitively suppressed by the more virulent clone, with DK achieving lower parasite densities when AS was present than when it was absent (figure 2a; table 1). However, the extent of competitive suppression of clone DK was similar regardless of CD4+T cell depletion (table 1; depletion×competition interaction, n.s.). Thus, there was no evidence that the competitive suppression of the total number of DK parasites present in an infection was mediated by CD4+T cell-dependent immunity.

However, repeated-measures analysis of the period where CD4+T cell depletion affected parasite densities (day 6 onwards) showed a weak but significant three-way depletion×competition×day interaction (table 2). To investigate this further, and following Råberg et al. (2006), we divided the data into three parts, days 6–8, 9–11 and 12–14, and repeated the analyses with each of these (figure 2a,c–e; table 3). During each of these time periods, there were significant depletion×competition or depletion×competition×day interactions. Inspection of figure 2a,c shows that the three-way interaction in the first period is a very weak effect from which it is difficult to conclude much, given the rapid alterations in infection kinetics during that period caused by depletion. In the other two periods, there are significant competition×depletion interactions (figures 2d,e; table 3), with more severe competitive suppression in CD4+T cell-depleted mice than in control mice. Thus, there was no evidence that competitive suppression is CD4+T cell mediated: once the initial wave of parasitaemia began to subside, competitive suppression was exacerbated rather than alleviated in CD4+-depleted mice.

(b) Clone AS

There was no evidence of competitive suppression of AS by DK, irrespective of the immune treatment (figure 2b; table 1). Repeated-measures analysis from day 6 onwards, when CD4+ depletion had an effect, revealed no evidence of interactions between depletion and competition (table 2). However, for comparison with the analysis of clone DK, we repeated the same analyses for AS on days 6–8, 9–11 and 12–14 (table 4). In none of these time periods was there any evidence of competitive suppression (in all cases, competition main effect and depletion×competition, p>0.15).

(c) Red blood cells

Red blood cell density over time for the different treatment groups are shown in figure 3. Uninfected red blood cells form an important resource for malaria parasites. To assess whether the potential for competition over this resource differed between CD4+-depleted and intact control mice, we compared the red blood cell densities in mice with mixed infections. Repeated-measures analysis of days 6–14 revealed that CD4+-depleted mice had significantly lower red blood cell densities during this time period (F1,34.7=4.35, p=0.045; figure 3). There was also a significant depletion×day interaction (F8,94.1=2.58, p=0.014). Separate analyses of days 6–8, 9–11 and 12–14 showed that the difference in RBC density was most pronounced during days 9–14 (table 5).

4. Discussion

We found no evidence that the CD4+T cells enhanced competition during mixed genotype infections with P. chabaudi (figure 2a; table 1). Specifically, during the peak stages of acute infection (days 6–8) suppression was independent of the CD4+T cells (figure 2c; table 3). After the peak of infection (day 9+), the CD4+T cells acted to alleviate competition such that upon their removal competitive suppression was enhanced (figure 2d,e; table 3). In addition, the presence of CD4+T cells did not cause suppression of the dominant genotype (figure 2b; table 4).

The immune response to Plasmodium infection has both pathogen genotype-transcending (non-specific) and genotype-specific components, with protection becoming more specific during later stages of infection (see §1). Here, we found that after the peak of acute infection (day 9 onwards), there was no competitive suppression of DK parasites in intact control mice; whereas in CD4+T cell-depleted mice, there was still evidence of competition (figure 2d,e; table 3). Both clones did better in depleted mice, probably owing to an impaired early antibody production through lack of T cell help and possibly the reduced recruitment and activation of macrophages for the uptake of infected cells. Thus, in normal hosts, a largely clone-specific adaptive immune response towards a numerically dominant genotype may act to alleviate competition by regulating clonal populations and limiting other forms of competition, e.g. competition for red blood cells.

During the peak of infection (days 6–8), competition was CD4+T cell independent so that the extent of competitive suppression of clone DK was similar in intact control and CD4+T cell-depleted mice (figure 2a,c; table 3). A number of biological mechanisms could be the proximate cause of competitive suppression during the peak of infection. First, there may be direct interference between two infecting strains. This has not yet been demonstrated in any parasites, but pathogenic bacteria can produce allelopathic substances that actively suppress competitors (Riley & Gordon 1999), and competing viruses can produce interference molecules (Hart & Cloyd 1990). Second, the competition may be influenced by non-specific components of the innate immune response (CD4+T cell independent). Third, there may be competition for resources as genotypes infecting mice simultaneously must divide the available red blood cells and other resources such as blood glucose between them (Hellriegel 1992; Hetzel & Anderson 1996; de Roode et al. 2005a; Gurarie et al. 2006). The CD4+T cell-depleted mice were more anaemic than control mice (figure 3; table 5), so that if red cells are limiting, there is more potential for competition for that resource in depleted mice. Mathematical models have suggested that during mixed infection, the proximate cause of competitive advantage may be attributable to an earlier and wider red blood cell preference of dominant genotypes (Hellriegel 1992; Gravenor et al. 1995; McKenzie & Bossert 1997; Jakeman et al. 1999; Mason & McKenzie 1999; McQueen et al. 2004; Antia et al. submitted). Because these predictions are based on the data from the rodent malaria model, they could be tested directly by transferring red blood cells of different ages into a single mouse and determine their loss following infection, or indirectly by measuring competition in untreated mice and mice treated with erythropoietin (Suzuki et al. 2006).

Our conclusion that competition is not CD4+T cell mediated apparently contradicts the recent finding of T cell-mediated apparent competition (Råberg et al. 2006). In that study, the authors looked at mixed infections with P. chabaudi in nude mice (which lack the ability to produce mature T cells) and compared the extent of competition with that in nude mice reconstituted with T cells. There was still pronounced competition in all animals, but there was some alleviation of competitive suppression in nude mice towards the end of the acute phase of infection, when the initial wave of parasitaemia was waning. This period corresponds roughly to days 9–14 in figure 2. A number of experimental differences could explain the contrasting results of Råberg et al. (2006) and the present study. First, different mouse strains were used in the two studies and host genotype has previously been shown to quantitatively affect the outcome of competition (de Roode et al. 2004). Second, different pairs of clones were used and P. chabaudi clone can induce different levels of strain-specific immunity (Cheesman et al. 2006). Third, there was a difference in the method used to modulate T cell-dependent immunity. Nude mice lack the ability to produce any mature T cells, including both CD4+ and CD8+T cells. The role of CD8+T cells during malaria infection in mice is still unclear (Lamb et al. 2006), but it could be that they are involved in the relatively small component of competition that was shown to be immune-mediated competition in reconstituted nude mice (Råberg et al. 2006). In addition, the repertoire of serum antibodies (including both natural antibodies and antigen elicited antibodies) in the CD4+T cell-depleted mice will be different from that in nude mice. Nude mice grow up producing only T cell-independent antibodies, while in the CD4+T cell-depleted mice there will be both T cell-independent and persisting T cell-dependent antibodies (produced by existing plasma cells in the bone marrow) and these may cross react with the parasite.

Taken together, the present study and that of Råberg et al. (2006) show that the effect of T cell-dependent immunity on competition is relatively weak, and may be either positive or negative depending on specific details of host and parasite. Rather than further dissection of any immune mechanism-mediating competition, one could use this malaria model system to look at the strength of competition in hosts immunized by a variety of different candidate vaccines towards the blood stage of infection. Meanwhile, the result we report here suggest that vaccines that enhance CD4+-dependent immunity will not increase the selection in favour of virulence arising from in-host competition.

We thank Andrea Graham for discussion; the March animal house for excellent husbandry; and two anonymous reviewers for stimulating comments. The work was supported by the Wellcome Trust and finished when A.R. was at the Wissenschaftskolleg zu Berlin.

References Alder F.R Losada J.M Super-and co-infection: filling the range Dieckmann U Metz J.A.J Sabelis M.W Sigmund K Adaptive dynamics of infectious diseases: in pursuit of virulence management 2002 Cambridge University Press Cambridge, UK 139 149 Anderson T.J.C Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum Mol. Biol. Evol 17 2000 1467 1482 11018154 Antia, R., Yates, A. & De Roode, J. C. Submitted. Virulence and competition in malaria infections. Arnot D Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission Trans. R. Soc. Trop. Med. Hyg 92 1998 580 585 doi:10.1016/S0035-9203(98)90773-8 10326095 Awadalla P Walliker D Babiker H.A Mackinnon M.J The question of Plasmodium falciparum population structure Trends Parasitol 17 2001 351 353 doi:10.1016/S1471-4922(01)02034-7 11685887 Beale G.H Walliker D Carter R Killick-Kendrick R Peters W Rodent malaria 1978 Academic Press London 213 245 Bell A.S de Roode J.C Sim D Read A.F Within-host competition in genetically diverse malaria infections: parasite virulence and competitive success Evolution 60 2006 1358 1371 16929653 Bremermann H.J Pickering J A game-theoretical model of parasite virulence J. Theor. Biol 100 1983 411 426 doi:10.1016/0022-5193(83)90438-1 6834864 Bruce M.C Donnelly C.A Alpers M.P Galinski M.R Barnwell J.W Walliker D Day K.P Cross-species interactions between malaria parasites in humans Science 287 2000 845 848 doi:10.1126/science.287.5454.845 10657296 Buckling A Read A.F The effect of partial host immunity on the transmission of malaria parasites Proc. R. Soc. B 268 2001 2325 2330 doi:10.1098/rspb.2001.1808 Cheesman S Raza A Carter R Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice Infect. Immunol 74 2006 2996 3001 doi:10.1128/IAI.74.5.2996-3001.2006 16622238 Daubersies P Sallenave-Sales S Magne S Trape J.-F Contamin H Fandeur T Rogier C Mercereau-Puijalon O Druilhe P Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area Am. J. Trop. Med. Hyg 54 1996 18 26 8651363 de Roode J.C Read A.F Chan H.K Mackinnon M.J Rodent malaria parasites suffer from the presence of con-specific clones in three-clone Plasmodium chabaudi infections Parasitology 127 2003 411 418 doi:10.1017/S0031182003004001 14653530 de Roode J.C Culleton R Cheesman S.J Carter R Read A.F Host heterogeneity is a determinant of competitive exclusion or coexistence in genetically diverse malaria infections Proc. R. Soc. B 271 2004 1073 1080 doi:10.1098/rspb.2004.2695 de Roode J.C Helinski M.E.H Anwar M.A Read A.F Dynamics of multiple infection and within-host competition in genetically diverse malaria infections Am. Nat 166 2005a 531 542 doi:10.1086/491659 16224719 de Roode J.C Virulence and competitive ability in genetically diverse malaria infections Proc. Natl Acad. Sci. USA 102 2005b 7624 7628 doi:10.1073/pnas.0500078102 15894623 Frank S.A Models of parasite virulence Q. Rev. Biol 71 1996 37 78 doi:10.1086/419267 8919665 Gandon S Mackinnon M.J Nee S Read A.F Imperfect vaccines and the evolution of pathogen virulence Nature 414 2001 751 756 doi:10.1038/414751a 11742400 Good M.F Doolan D.L Immune effector mechanisms in malaria Curr. Opin. Immunol 11 1999 412 419 doi:10.1016/S0952-7915(99)80069-7 10448141 Gravenor M.B McLean A.R Kwiatkowski D The regulation of malaria parasitemia–parameter estimates for a population-model Parasitology 110 1995 115 122 7885729 Gurarie D Zimmerman P.A King C.H Dynamic regulation of single- and mixed-species malaria infection: insights to specific and non-specific mechanisms of control J. Theor. Biol 240 2006 185 199 doi:10.1016/j.jtbi.2005.09.015 16263133 Hart A.R Cloyd M.W Interference patterns of human immunodeficiency viruses HIV-1 and HIV-2 Virology 177 1990 1 10 2191494 Hastings I.M A model for the origins and spread of drug-resistant malaria Parasitology 115 1997 133 141 doi:10.1017/S0031182097001261 10190169 Hastings I.M Malaria control and the evolution of drug resistance: an intriguing link Trends Parasitol 19 2003 70 73 doi:10.1016/S1471-4922(02)00017-X 12586474 Hastings I.M Complex dynamics and stability of resistance to antimalarial drugs Parasitology 132 2006 615 624 doi:10.1017/S0031182005009790 16426485 Hastings I.M D'Alessandro U Modelling a predictable disaster: the rise and spread of drug-resistant malaria Parasitol. Today 16 2000 340 347 doi:10.1016/S0169-4758(00)01707-5 10900482 Hellriegel B Modelling the immune response to malaria with ecological concepts: short-term behaviour against long-term equilibrium Proc. R. Soc. B 250 1992 249 256 doi:10.1098/rspb.1992.0156 Hetzel C Anderson R The within-host cellular dynamics of blood-stage malaria: theoretical and experimental studies Parasitology 113 1996 25 38 8710412 Holt R.D Predation, apparent competition, and the structure of prey communities Theor. Popul. Biol 12 1977 197 229 doi:10.1016/0040-5809(77)90042-9 929457 Hviid L Kurtzhals J.A Goka B.Q Oliver-Commey J.O Nkrumah F.K Theander T.G Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria Infect. Immunol 65 1997 4090 4093 9317012 Jafari S Le Bras J Bouchaud O Durand R Plasmodium falciparum clonal population dynamics during malaria treatment J. Infect. Dis 189 2004 195 203 doi:10.1086/380910 14722883 Jakeman G Saul A Hogarth W Collins W Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes Parasitology 119 1999 127 133 doi:10.1017/S0031182099004564 10466119 Jarra W Brown K.N Invasion of mature and immature erythrocytes of CBA/ca mice by a cloned line of Plasmodium chabaudi chabaudi Parasitology 99 1989 157 163 2594410 Lamb T.J Brown D.E Potocnik A.J Langhorne J Insights into the immunopathogenesis of malaria using mouse models Expert Rev. Mol. Med 8 2006 1 22 16556343 Lipsitch M Samore M.H Antimicrobial use and antimicrobial resistance: a population perspective Emerg. Infect. Dis 8 2002 347 354 11971765 Mackinnon M.J Drug resistance models for malaria Acta Tropica 94 2005 207 217 doi:10.1016/j.actatropica.2005.04.006 15894181 Mackinnon M.J Hastings I.M The evolution of multiple drug resistance in malaria parasites Trans. R. Soc. Trop. Med. Hyg 92 1998 188 195 doi:10.1016/S0035-9203(98)90745-3 9764331 Mackinnon M.J Read A.F Genetic relationships between parasite virulence and transmission in the rodent malaria Plasmodium chabaudi Evolution 53 1999 689 703 doi:10.2307/2640710 Mackinnon M.J Read A.F The effects of host immunity on virulence transmission relationships in the rodent malaria parasite Plasmodium chabaudi Parasitology 126 2003 103 112 doi:10.1017/S003118200200272X 12636347 Martinelli A Cheesman S Hunt P Culleton R Raza A Mackinnon M Carter R A genetic approach to the de novo identification of targets of strain specific immunity in malaria parasites Proc. Natl Acad. Sci. USA 102 2005 814 819 doi:10.1073/pnas.0405097102 15640359 Mason D.P McKenzie F.E Blood-stage dynamics and clinical implications of mixed Plasmodium vivax–Plasmodium falciparum infections Am. J. Trop. Med. Hyg 61 1999 367 374 10497972 McKenzie F.E Bossert W.H The dynamics of Plasmodium falciparum blood-stage infection J. Theor. Biol 188 1997 127 140 doi:10.1006/jtbi.1997.0478 9299316 McQueen P.G McKenzie F.E Singer B.H Age-structured red blood cell susceptibility and the dynamics of malaria infections Proc. Natl Acad. Sci. USA 101 2004 9161 9166 doi:10.1073/pnas.0308256101 15178766 Mercereau-Puijalon O Revisiting host/parasite interactions: molecular analysis of parasites collected during longitudinal and cross-sectional surveys in humans Parasite Immunol 18 1996 173 180 doi:10.1046/j.1365-3024.1996.d01-79.x 9223172 Pombo D.J Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum Lancet 360 2002 610 617 doi:10.1016/S0140-6736(02)09784-2 12241933 Råberg L de Roode J.C Bell A.S Stamou P Gray D Read A.F The role of immune-mediated apparent competition in genetically diverse malaria infections Am. Nat 168 2006 41 53 doi:10.1086/505160 16874614 Read A.F Mackinnon M.J Pathogen evolution in a vaccinated world Stearns S.C Koella J Evolution in health and disease 2nd edn 2008 Oxford University Press Oxford, UK Read A.F Taylor L.H The ecology of genetically diverse infections Science 292 2001 1099 1102 doi:10.1126/science.1059410 11352063 Riley M.A Gordon D.M The ecological role of bacteriocins in bacterial competition Trends Microbiol 7 1999 129 133 doi:10.1016/S0966-842X(99)01459-6 10203843 Smith T Felger I Kitua A Tanner M Beck H.P Dynamics of multiple Plasmodium falciparum infections in infants in a highly endemic area of Tanzania Trans. R. Soc. Trop. Med. Hyg 93 1999 35 39 doi:10.1016/S0035-9203(99)90325-5 10450424 Stephens R Langhorne J Priming CD4+T cells and development of CD4+T cell memory; lessons for malaria Parasite Immunol 28 2006 25 30 doi:10.1111/j.1365-3024.2006.00767.x 16438673 Stevenson M.M Riley E.M Innate immunity to malaria Nat. Rev. Immunol 4 2004 169 180 doi:10.1038/nri1311 15039754 Suzuki M Ohneda K Hosoya-Ohmura S Tsukamoto S Ohneda O Philipsen S Yamamoto M Real-time monitoring of stress erythropoiesis in vivo using Gata1 and beta-globin LCR luciferase transgenic mice Blood 108 2006 726 733 doi:10.1182/blood-2005-10-4064 16537808 Talisuna A.O Erhart A Samarasinghe S Van Overmeir C Speybroeck N D'Alessandro U Malaria transmission intensity and the rate of spread of chloroquine resistant Plasmodium falciparum: why have theoretical models generated conflicting results? Infect. Gen. Evol 6 2006 241 248 doi:10.1016.j.meegid.2005/06.003 Timms R Colegrave N Chan B.H.K Read A.F The effect of parasite dose on disease severity in the rodent malaria Plasmodium chabaudi Parasitology 123 2001 1 11 doi:10.1017/S0031182001008083 11467777 Urban B.C Ing R Stevenson M.M Early interactions between blood-stage plasmodium parasites and the immune system Curr. Top. Microbiol. Immunol 297 2005 25 70 16265902 van Baalan M Sabelis M.W The dynamics of multiple infection and the evolution of virulece Am. Nat 146 1995 881 910 doi:10.1086/285830 Walliker D Hunt P Babiker H Fitness of drug-resistant malaria parasites Acta Tropica 94 2005 251 259 doi:10.1016/j.actatropica.2005.04.005 15845348

FACS plots of number of cells analysed and percentage of CD4+T cells in (a) CD4+T cell-depleted and (b) intact control mice. Percentage of the CD4+T cells was analysed: (i) 1 day before parasite challenge and (ii–iv) once a week throughout the experiment. Each graph is a representative of one mouse from either the CD4+T cell-depleted or immunocompetent control group.

Parasite densities through time of (a) clone DK and (b) clone AS, and (c–e) average densities of DK during the periods denoted by the vertical dashed lines. Asexual density from qPCR of CD4+T cell-depleted mice and intact control (normal) mice with single infections in CD4+T cell-depleted mice and mixed infections in intact control (normal) mice. Mean densities (±1 s.e.m.) were calculated from all mice that were alive on the respective day of sampling (up to five). The interaction plots (c–e) show the total numbers of DK parasites when the competitor clone AS is absent (single infection) or present (mixed infection) in CD4+-depleted mice (dashed lines) and normal animals (solid lines). Competition×depletion interactions: (c) F1,16=1, p=0.33; (d) F1,17=5.11, p=0.037; and (e) F1,14=4.57, p=0.0499 (open squares, CD4+-depleted single; open triangles, intact single; filled squares, CD4+-depleted mixed; filled triangles, intact mixed).

Mean red blood cell densities (±1 s.e.m) over time. (a) CD4+T cell-depleted and intact mice infected with DK (squares, depleted single; triangles, intact single), (b) depleted and intact mice infected with AS (squares, depleted single; triangles, intact single), and (c) depleted and intact mice infected with DK and AS (squares, depleted mixed; triangles, intact mixed).

GLM analyses of the effects of CD4+T cell depletion, competition (presence/absence of co-infecting clone) and their interaction on the total number of parasites during the first two weeks of infection for parasite clone DK and AS.

DK days 2–14 AS days 2–14


effect d.f. F p d.f. F p
CD4+ depletion 1,15 82.7 <0.001 1,15 93.36 <0.000
competition 1,15 84.2 <0.001 1,15 2.05 0.17
CD4+ depletion×competition 1,15 0.6 0.74 1,15 0.94 0.94

Repeated-measures analyses of the effects of CD4+ depletion, competition (presence/absence of co-infecting clone) and day post-infection on the daily densities of the two parasite clones DK and AS for days 6–14 post-infection.

DK days 6–14 AS days 6–14


effect d.f. F p d.f. F p
CD4+ depletion 1,16 74.52 <0.0001 1,17 51.58 <0.0001
competition 1,16 17.92 0.0006 1,17 1.86 0.19
day 8,101 30.8 <0.0001 8,108 40.85 <0.0001
CD4+ depletion×competition 1,16 2.65 0.12 1,17 0.02 0.88
CD4+ depletion×day 8,101 22.35 <0.0001 8,108 15.67 <0.0001
competition×day 8,101 3.67 0.0009 8,108 0.91 0.51
CD4+ depletion× competition×day 8,101 2.10 0.042 8,108 0.47 0.87

Repeated-measures analyses of the effects of CD4+ depletion, competition (presence/absence of co-infecting clone) and day post-infection on the daily parasite density of clone DK for days 6–8, 9–11 and 12–14 post-infection.

days 6–8 days 9–11 days 12–14



effect d.f. F p d.f. F p d.f. F p
CD4+ depletion 1,16 12.61 0.0026 1,17 54.79 <0.0001 1,14 105.95 <0.0001
competition 1,16 62.31 <0.001 1,17 47.53 <0.0001 1,14 1.33 0.26
day 2,29 15.32 <0.001 2,30 39.12 <0.0001 2,28 2.22 0.12
CD4+ depletion× competition 1,16 1 0.33 1,17 5.11 0.037 1,14 4.57 0.049
CD4+ depletion× day 2,29 2.88 0.071 2,30 11.87 0.0002 2,28 23.78 <0.0001
competition×day 2,29 12.34 0.0001 2,30 2.32 0.11 2,28 0.64 0.53
CD4+ depletion× competition×day 2,29 3.78 0.034 2,30 2.3 0.11 2,28 0.17 0.84

Repeated-measures analyses of the effects of CD4+ depletion, competition (presence/absence of co-infecting clone) and day post-infection on the daily parasite density of clone AS for days 6–8, 9–11 and 12–14 post-infection.

days 6–8 days 9–11 days 12–14



effect d.f. F p d.f. F p d.f. F p
CD4+ depletion 1,14 17.58 0.0008 1,15 31.83 <0.001 1,14 58.71 <0.001
competition 1,14 0.3 0.58 1,15 2.08 0.16 1,14 1.6 0.22
day 2,28 39.82 <0.001 2,29 89.06 <0.001 2,27 6.52 0.0049
CD4+ depletion× competition 1,14 0.01 0.91 1,15 0.11 0.74 1,14 0.03 0.86
CD4+ depletion ×day 2,28 12.17 0.0001 2,29 3.03 0.06 2,27 15.34 <0.001
competition×day 2,28 0.22 0.8 2,29 3.13 0.058 2,27 0.76 0.47
CD4+ depletion×competition×day 2,28 1.20 0.31 2,29 0.08 0.92 2,27 0.70 0.50

Repeated-measures analyses of the effects of CD4+ depletion and day post-infection on the mean red blood cell density in mixed infections during days 6–8, 9–11 and 12–14.

days 6–8 days 9–11 days 12–14



effect d.f. F p d.f. F p d.f. F p
CD4+ depletion 1,21 1.77 0.14 1,23 10.75 0.0033 1,19 4.57 0.045
day 2,36 42.18 <0.001 2,37 11.98 <0.0001 2,38 0.33 0.72
CD4+ depletion× day 2,26 3.18 0.05 2,37 0.65 0.52 2,28 0.08 0.92